Trials / Recruiting
RecruitingNCT05371886
Pharmacokinetics-pharmacodynamics of Morphine With or Without Midazolam Administered by Continuous Infusion in Neonatal Intensive Care
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Centre Hospitalier Intercommunal Creteil · Academic / Other
- Sex
- All
- Age
- 20 Weeks – 45 Weeks
- Healthy volunteers
- Not accepted
Summary
This study aims to describe a dose-effect relationship of morphine alone and morphine and midazolam administered as continuous infusion in neonates hospitalized in Neonatal intensive care unit and undergoing mechanical ventilation, through PKPD modelling.
Detailed description
This study will include all neonates receiving a sedo-analgesia with continuous infusion of morphine alone or morphine and midazolam during mechanical ventilation in 3 French NICUs. Comfort and pain will be assessed by COMFORTneo pain scores and Newborn Infant Parasympathetic Evaluation Index. Morphine, midazolam and their metabolites' concentrations will be determined on samples taken during a planned blood test. Through PKPD modelling, the dose-concentration-effect relationships will be found and interindividual variability of these drugs in neonates and simulate doses needed to achieve comfort in neonates according to their individual characteristics (gestational age, post-natal age, weight etc.).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dose-effect relationship of morphine +/- midazolam administration | Dose-effect relationship of morphine +/- midazolam administration as continuous infusion in neonates undergoing mechanical ventilation through PKPD modelling |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2023-07-01
- Completion
- 2027-05-01
- First posted
- 2022-05-12
- Last updated
- 2025-11-17
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05371886. Inclusion in this directory is not an endorsement.